SLC7A11 and non-small cell lung carcinoma: ,107, 108, 109 For example, SLC7A11-mediated metabolic reprogramming promotes non-small cell lung cancer progression and inhibition of SLC7A11 transporter activity in SLC7A11 overexpressing non-small cell lung cancer cells with sulfasalazine decreases cell proliferation and invasion in vitro and in vivo.107